• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘌呤能信号紊乱抑制CD39/Entpd1基因敲除小鼠的病理性血管生成。

Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

作者信息

Jackson Shaun W, Hoshi Tomokazu, Wu Yan, Sun Xiaofeng, Enjyoji Keiichi, Cszimadia Eva, Sundberg Christian, Robson Simon C

机构信息

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Am J Pathol. 2007 Oct;171(4):1395-404. doi: 10.2353/ajpath.2007.070190. Epub 2007 Sep 6.

DOI:10.2353/ajpath.2007.070190
PMID:17823293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1988887/
Abstract

CD39/ecto-nucleoside triphosphate diphosphohydrolase-type-1 (ENTPD1) is the dominant vascular ecto-nucleotidase that catalyzes the phosphohydrolysis of extracellular nucleotides in the blood and extracellular space. This ecto-enzymatic process modulates endothelial cell, leukocyte, and platelet purinergic receptor-mediated responses to extracellular nucleotides in the setting of thrombosis and vascular inflammation. We show here that deletion of Cd39/Entpd1 results in abrogation of angiogenesis, causing decreased growth of implanted tumors and inhibiting development of pulmonary metastases. Qualitative abnormalities of Cd39-null endothelial cell adhesion and integrin dysfunction were demonstrated in vitro. These changes were associated with decreased activation of focal adhesion kinase and extracellular signaling-regulated kinase-1 and -2 in endothelial cells. Our data indicate novel links between CD39/ENTPD1, extracellular nucleotide-mediated signaling, and vascular endothelial cell integrin function that impact on angiogenesis and tumor growth.

摘要

CD39/外核苷三磷酸二磷酸水解酶-1型(ENTPD1)是主要的血管外核苷酸酶,可催化血液和细胞外空间中细胞外核苷酸的磷酸水解。这种外酶促过程在血栓形成和血管炎症的情况下调节内皮细胞、白细胞和血小板嘌呤能受体介导的对细胞外核苷酸的反应。我们在此表明,Cd39/Entpd1的缺失导致血管生成的废除,导致植入肿瘤的生长减少并抑制肺转移的发展。体外证实了Cd39基因缺失的内皮细胞粘附和整合素功能障碍的定性异常。这些变化与内皮细胞中粘着斑激酶和细胞外信号调节激酶-1和-2的激活减少有关。我们的数据表明,CD39/ENTPD1、细胞外核苷酸介导的信号传导和血管内皮细胞整合素功能之间存在新的联系,这些联系会影响血管生成和肿瘤生长。

相似文献

1
Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.嘌呤能信号紊乱抑制CD39/Entpd1基因敲除小鼠的病理性血管生成。
Am J Pathol. 2007 Oct;171(4):1395-404. doi: 10.2353/ajpath.2007.070190. Epub 2007 Sep 6.
2
Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.嘌呤能信号紊乱和细胞代谢异常与 Cd39/ENTPD1 基因敲除小鼠肝癌的发生发展有关。
Hepatology. 2013 Jan;57(1):205-16. doi: 10.1002/hep.25989.
3
Deletion of cd39/entpd1 results in hepatic insulin resistance.cd39/entpd1的缺失会导致肝脏胰岛素抵抗。
Diabetes. 2008 Sep;57(9):2311-20. doi: 10.2337/db07-1265. Epub 2008 Jun 20.
4
Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.血管 CD39/ENTPD1 通过清除细胞外三磷酸腺苷直接促进肿瘤细胞生长。
Neoplasia. 2011 Mar;13(3):206-16. doi: 10.1593/neo.101332.
5
Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.CD39基因敲除小鼠中的自然杀伤T细胞功能障碍可预防伴刀豆球蛋白A诱导的肝炎。
Hepatology. 2008 Sep;48(3):841-52. doi: 10.1002/hep.22401.
6
Disordered cellular migration and angiogenesis in cd39-null mice.CD39基因敲除小鼠中细胞迁移和血管生成紊乱。
Circulation. 2001 Dec 18;104(25):3109-15. doi: 10.1161/hc5001.100663.
7
Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.人外切核苷三磷酸二磷酸水解酶-1和/或外切5'-核苷酸酶在猪内皮细胞中表达的功能分析
Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):313-8. doi: 10.1080/15257770.2014.896466.
8
Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.CD39基因敲除小鼠的胰腺炎症反应紊乱及纤维化抑制
Gastroenterology. 2008 Jan;134(1):292-305. doi: 10.1053/j.gastro.2007.10.030. Epub 2007 Oct 25.
9
CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.CD4+Foxp3+调节性 T 细胞表达 CD39/ENTPD1 促进小鼠肝转移瘤生长。
Gastroenterology. 2010 Sep;139(3):1030-40. doi: 10.1053/j.gastro.2010.05.007. Epub 2010 Jun 25.
10
Purinergic dysregulation in pulmonary hypertension.嘌呤能调节异常与肺动脉高压
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H286-98. doi: 10.1152/ajpheart.00572.2015. Epub 2016 May 20.

引用本文的文献

1
Insights from Clinical Trials on A Adenosine Receptor Antagonists for Cancer Treatment.A腺苷受体拮抗剂用于癌症治疗的临床试验见解。
ACS Pharmacol Transl Sci. 2025 May 2;8(6):1498-1512. doi: 10.1021/acsptsci.5c00057. eCollection 2025 Jun 13.
2
ATP released by ultrasound targeted microbubble cavitation induces vascular inflammation and improves immune checkpoint blockade efficacy.超声靶向微泡空化释放的三磷酸腺苷诱导血管炎症并提高免疫检查点阻断疗效。
Theranostics. 2025 Apr 11;15(11):5220-5237. doi: 10.7150/thno.105857. eCollection 2025.
3
Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.调节性 T 细胞治疗乳腺癌的策略:整体到局部方面。
Cells. 2024 Sep 11;13(18):1526. doi: 10.3390/cells13181526.
4
Platelets induce CD39 expression in tumor cells to facilitate tumor metastasis.血小板诱导肿瘤细胞表达 CD39 以促进肿瘤转移。
Br J Cancer. 2024 May;130(9):1542-1551. doi: 10.1038/s41416-024-02640-8. Epub 2024 Mar 9.
5
Unlocking antitumor immunity with adenosine receptor blockers.用腺苷受体阻滞剂开启抗肿瘤免疫。
Cancer Drug Resist. 2023 Oct 25;6(4):748-767. doi: 10.20517/cdr.2023.63. eCollection 2023.
6
NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow.NTPDase1/CD39 核苷酸酶对正常动脉直径适应血流至关重要。
Int J Mol Sci. 2023 Oct 10;24(20):15038. doi: 10.3390/ijms242015038.
7
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.癌症免疫逃逸机制的靶点:癌症免疫检查点抑制剂研发与演变的基础
Biology (Basel). 2023 Jan 30;12(2):218. doi: 10.3390/biology12020218.
8
Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes.高级别浆液性卵巢癌模型的蛋白质组学分析鉴定与临床结局相关的癌症相关成纤维细胞标志物。
Biomolecules. 2022 Dec 30;13(1):75. doi: 10.3390/biom13010075.
9
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models.糖基化工程抗 CD39 通过耗竭抑制性细胞和抑制肿瘤模型中的血管生成来促进抗癌反应。
J Clin Invest. 2022 Jul 1;132(13). doi: 10.1172/JCI157431.
10
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.癌症中的 ATP 和腺苷代谢:治疗增益的探索。
Pharmacol Rev. 2022 Jul;74(3):797-822. doi: 10.1124/pharmrev.121.000528.

本文引用的文献

1
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.调节性T细胞上表达的CD39和CD73催化生成的腺苷介导免疫抑制。
J Exp Med. 2007 Jun 11;204(6):1257-65. doi: 10.1084/jem.20062512. Epub 2007 May 14.
2
A2A adenosine receptor protects tumors from antitumor T cells.A2A 腺苷受体保护肿瘤免受抗肿瘤 T 细胞的攻击。
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13132-7. doi: 10.1073/pnas.0605251103. Epub 2006 Aug 17.
3
Antitumor activity of IFN-lambda in murine tumor models.干扰素-λ在小鼠肿瘤模型中的抗肿瘤活性。
J Immunol. 2006 Jun 15;176(12):7686-94. doi: 10.4049/jimmunol.176.12.7686.
4
RanBPM associates with CD39 and modulates ecto-nucleotidase activity.RanBPM与CD39结合并调节胞外核苷酸酶活性。
Biochem J. 2006 May 15;396(1):23-30. doi: 10.1042/BJ20051568.
5
Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways.细胞外核苷酸对内皮细胞迁移的调节作用:粘着斑激酶和磷脂酰肌醇3-激酶介导途径的参与
Thromb Haemost. 2005 Apr;93(4):735-42. doi: 10.1160/TH04-09-0576.
6
Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis.腺苷A(2A)受体激活通过刺激血管生成和血管发生促进伤口新生血管形成。
Am J Pathol. 2004 Jun;164(6):1887-92. doi: 10.1016/S0002-9440(10)63749-2.
7
RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1.RanBPM是一种磷蛋白,与质膜相关联并与整合素LFA-1相互作用。
J Biol Chem. 2004 Mar 26;279(13):13027-34. doi: 10.1074/jbc.M313515200. Epub 2004 Jan 13.
8
Integrins in angiogenesis: multitalented molecules in a balancing act.血管生成中的整合素:平衡行为中的多能分子
Cell Tissue Res. 2003 Oct;314(1):131-44. doi: 10.1007/s00441-003-0774-5. Epub 2003 Sep 10.
9
Focal adhesion kinase: the first ten years.粘着斑激酶:头十年
J Cell Sci. 2003 Apr 15;116(Pt 8):1409-16. doi: 10.1242/jcs.00373.
10
Regulation of G protein-coupled receptor signaling by scaffold proteins.支架蛋白对G蛋白偶联受体信号传导的调控。
Circ Res. 2002 Oct 18;91(8):672-80. doi: 10.1161/01.res.0000037000.74258.03.